|
|
|
|
|
ABSTRACT:
The emphasis of this chapter will be on the application of bioinformatics tools and database to identify and characterize novel gene targets, which is of interest to pharmaceutical companies. A pharmaceutical bioinformatics must design a system a system for converting bulk data and analyses into experimentalist-accessible knowledge. The integration of bioinformatics, molecular biotechnology and epidemiological methods of assessing disease risk is rapidly expanding our ability to identify genetic influences on complex human disease.
|
|
|
|
STATISTICS
|
|
Click on # to view
|
|
Citations
|
|
0
|
|
References
|
|
0
|
|
Comments
|
|
0
|
|
Quality
|
|
0/0.00
|
|
Interest
|
|
0/0.00
|
|
View(er)s
|
|
1/111
|
|
|
|
|
|
|
| Prev |
Next |
|